Neural transplantation and restoration of motor behaviour in Parkinson's disease

Samii's Essentials in Neurosurgery

Volumn , Issue , 2008, Pages 35-48

  Klein, Alexander ^a   Nikkah, Guido ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891381681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-49250-4_5     Document Type: Chapter

References (143)

1. Abrous DN, Torres EM, Dunnett SB (1993) Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Neuroscience 3:657-668
2. Ahlskog JE, Muenter MD (2001) Frequency of levodoparelated dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 3:448-458
3. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 10:366-375
4. Albin RL, Young AB, Penney JB (1995) The functional anatomy of disorders of the basal ganglia. Trends Neurosci 2:63-64
5. Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P (1999) Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 2:217-223
6. Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN (2006) Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 5:379-388
7. Bentlage C, Nikkhah G, Cunningham MG, Bjorklund A (1999) Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp Neurol 1:177-190
8. Bezard E, Brotchie JM, Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 8:577-588
9. Bicknese AR, Goodwin HS, Quinn CO, Henderson VC, Chien SN, Wall DA (2002) Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant 3:261-264
10. Birkmayer W, Hornykiewicz O (2001) The effect of 1-3,4- dihydroxyphenylalanine (L-DOPA) on akinesia in parkinsonism (1961). Wien Klin Wochenschr 113:851-854
11. Birkmayer W, Riederer P (1985) Die Parkinson-Krankheit: Biochemie, Klinik, Therapie. Springer, Wien, New York
12. Bjorklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 3:555-560
13. Bjorklund A, Stenevi U (1985) Intracerebral neural grafting: a historical perspective. In: Bjorklund A, Stenevi U (eds) Neural Grafting in the Mammalian CNS. pp Elsevier, Amsterdam, pp 3-14
14. Bjorklund A, Dunnett SB, Nikkhah G (1994) Nigral transplants in the rat Parkinson model. Functional limitations and strategies to enhance nigrostriatal reconstructions. In: Dunnet SB, Bjorklund A (eds) Functional Neural Transplantation. Raven, New York, pp 47-69
15. Bjorklund A, Stenevi U, Schmidt RH, Dunnett SB, Gage FH (1983) Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand Suppl 522:9-18
16. Brown J, Cooper-Kuhn CM, Kempermann G, van Praag H, Winkler J, Gage FH, Kuhn HG (2003) Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 10:2042-2046
17. Brown AM, Deutch AY, Colbran RJ (2005) Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci 1:247-256
18. Brundin P, Duan WM, Sauer H (1994) Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Dunnet B, Bjorklund A (eds) Functional Neural Transplantation. Raven, New York, pp 9-46
19. Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, Rehncrona S, Lindvall O (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123:1380-1390
20. Calne DB, Zigmond MJ (1991) Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol 4:361-363
21. Carli M, Evenden JL, Robbins TW (1985) Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 6004:679-682
22. Carlsson T, Bjorklund T, Kirik D (2007) Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy. Curr Gene Ther 2:109-120
23. Carlsson T, Winkler C, Burger C, Muzyczka N, Mandel RJ, Cenci A, Bjorklund A, Kirik D (2005) Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain 128:559-569
24. Carlsson T, Winkler C, Lundblad M, Cenci MA, Bjorklund A, Kirik D (2006) Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol Dis 3:657-668
25. Cenci MA, Hagell P (2005) Dyskinesia and Neural Grafting in Parkinson's Disease. Kluver Academic/Plenum, New York
26. Cenci MA, Campbell K, Bjorklund A (1993) Neuropeptide messenger RNA expression in the 6-hydroxydopaminelesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 2:275-296
27. Cenci MA, Campbell K, Bjorklund A (1997) Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum: effects of intrastriatal fetal nigral transplants or chronic apomorphine treatment. Brain Res Mol Brain Res 1:149-155
28. Cenci MA, Whishaw IQ, Schallert T (2002) Animal models of neurological deficits: how relevant is the rat? Nat Rev Neurosci 7:574-579
29. Chkirate M, Vallee A, Doucet G (1993) Host striatal projections into fetal ventral mesencephalic tissue grafted to the striatum of immature or adult rat. Exp Brain Res 2:357-362
30. Chritin M, Savasta M, Mennicken F, Bal A, Abrous DN, Le Moal M, Feuerstein C, Herman JP (1992) Intrastriatal dopamine-rich Implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridization study. Eur J Neurosci 7:663-672
31. Clarke DJ, Brundin P, Strecker RE, Nilsson OG, Bjorklund A, Lindvall O (1988). Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp Brain Res 1:115-126
32. Cotzias GC, Van Woert MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 7:374-379
33. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, Neville BG, Giovannoni G (2004) Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 127:21-33
34. de Medinaceli L, Freed WJ, Wyatt RJ (1982) An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 3:634-643
35. Dobrossy MD, Dunnett SB (2003) Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol 1:274-284
36. Dobrossy MD, Dunnett SB (2004) Environmental enrichment affects striatal graft morphology and functional recovery. Eur J Neurosci 1:159-168
37. Dobrossy MD, Drapeau E, Aurousseau C, Le Moal M, Piazza PV, Abrous DN (2003) Differential effects of learning on neurogenesis: learning increases or decreases the number of newly born cells depending on their birth date. Mol Psychiatry 12:974-982
38. Dobrossy MD, Le Moal M, Montaron MF, Abrous N (2000) Influence of environment on the efficacy of intrastriatal dopaminergic grafts. Exp Neurol 1:172-183
39. Doucet G, Murata Y, Brundin P, Bosler O, Mons N, Geffard M, Ouimet CC, Bjorklund A (1989) Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp Neurol 1:1-19
40. Dunnett SB, Bjorklund A (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 6738:A32-A39
41. Dunnett SB, Bjorklund A, Schmidt RH, Stenevi U, Iversen SD (1983) Intracerebral grafting of neuronal cell suspensions. V. Behavioural recovery in rats with bilateral 6-OHDA lesions following implantation of nigral cell suspensions. Acta Physiol Scand Suppl 522:39-47
42. Dunnett SB, Whishaw IQ, Rogers DC, Jones GH (1987) Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res 1:63-78
43. Eslamboli A, Georgievska B, Ridley RM, Baker HF, Muzyczka N, Burger C, Mandel RJ, Annett L, Kirik D (2005) Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J Neurosci 4:769-777
44. Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 4:306-318
45. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283-2301
46. Fouad K, Klusman I, Schwab ME (2004) Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur J Neurosci 9:2479-2482
47. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 10:710-719
48. Freund TF, Bolam JP, Bjorklund A, Stenevi U, Dunnett SB, Powell JF, Smith AD (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci 3 603-616
49. Fricker-Gates RA, Dunnett SB (2002) Rewiring the Parkinsonian brain. Nat Med 2:105-106
50. Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 5532:1164-1166
51. Fuente-Fernandez R, Stoessl AJ (2002) The placebo effect in Parkinson's disease. Trends Neurosci 6:302-306
52. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J (1995) Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A 25:11879-11883
53. Gasser T (2005) Genetics of Parkinson's disease. Curr Opin Neurol 4:363-369
54. Graybiel AM (1995) Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 6:733-741
55. Graybiel AM (2000) The basal ganglia. Curr Biol 14: R509-R511
56. Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E (2005) Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. Eur J Neurosci 1:283-287
57. Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O (1999) Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:1121-1132
58. Harel NY, Strittmatter SM (2006) Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci 8:603-616
59. Hefti F, Melamed E, Sahakian BJ, Wurtman RJ (1980) Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav 2:185-188
60. Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 6180:345-348
61. Hirsch E.C, Hoglinger G, Rousselet E, Breidert T, Parain K, Feger J, Ruberg M, Prigent A, Cohen-Salmon C, Launay JM (2003) Animal models of Parkinson's disease in rodents induced by toxins: an update. J Neural Transm Suppl 65:89-100
62. Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol 3:S115-S120
63. Jellinger K (1974) Pathomorphologie des Parkinson-Syndroms. Aktuel Neurol 1:83-98
64. Jellinger KA (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 3:153-197
65. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:S26-S36
66. Jenner P, Olanow CW (1998) Understanding cell death in Parkinson's disease. Ann Neurol 3:S72-S84
67. Kempermann G, Gast D, Gage FH (2002) Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann Neurol 2:135-143
68. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 6893:50-56
69. Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 2:259-277
70. Klein A, Metz GA, Papazoglou A, Nikkhah G (2007) Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol Dis (in press)
71. Knowlton BJ, Squire LR (1995) Remembering and knowing: two different expressions of declarative memory. J Exp Psychol Learn Mem Cogn 3:699-710
72. Knowlton BJ, Mangels JA, Squire LR (1996) A neostriatal habit learning system in humans. Science 5280:1399-1402
73. Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW (1998) Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 3:383-393
74. Kordower JH, Freeman TB, Olanow CW (1998) Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov Disord 13:88-95
75. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 17:1118-1124
76. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen EY, Li JM, Martel L, Levey AE, Mufson EJ, Freeman TB, Olanow CW (1996) Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 2:203-230
77. Lane EL, Winkler C, Brundin P, Cenci MA (2006) The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis 2:334-345
78. Lang AE, Lozano AM (1998) Parkinson's disease. Second of two parts. N Engl J Med 16:1130-1143
79. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 6:675-679
80. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 16:1105-1111
81. Lindvall O, Hagell P (2000) Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 127:299-320
82. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 4942:574-577
83. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Bjorklund A, Leenders KL, Rothwell JC (1990) Neural transplantation in Parkinson's disease: the Swedish experience. Prog Brain Res 82:729-734
84. MacRae PG, Spirduso WW, Wilcox RE (1988) Reaction time and nigrostriatal dopamine function: the effects of age and practice. Brain Res 451:139-146
85. Mandel RJ, Brundin P, Bjorklund A (1990) The Importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur J Neurosci 10:888-894
86. Markus TM Tsai SY, Bollnow MR, Farrer RG, O'Brien TE, Kindler-Baumann DR, Rausch M, Rudin M, Wiessner C, Mir AK, Schwab ME, Kartje GL (2005) Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol 6:950-953
87. Marsden CD (1990) Parkinson's disease. Lancet 8695:948-952
88. Mendez I, Elisevich K, Flumerfelt B (1991) Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study. J Comp Neurol 1:66-78
89. Metz GA, Whishaw IQ (2000) Skilled reaching an action pattern: stability in rat (Rattus norvegicus) grasping movements as a function of changing food pellet size. Behav Brain Res 2:111-122
90. Metz GA, Whishaw IQ (2002) Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore-and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2:169-179
91. Metz GA, Tse A, Ballermann M, Smith LK, Fouad K (2005) The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis. Eur J Neurosci 3:735-744
92. Miklyaeva EI, Castaneda E, Whishaw IQ (1994) Skilled reaching deficits in unilateral dopamine-depleted rats: impairments in movement and posture and compensatory adjustments. J Neurosci 11:7148-7158
93. Mink JW, Thach WT (1993) Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 6:950-957
94. Montoya CP, Astell S, Dunnett SB (1990) Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog Brain Res 82:459-466
95. Nikkhah G, Bentlage C, Cunningham MG, Bjorklund A (1994) Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 6:3449-3461
96. Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Bjorklund A (1995) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci 5:3548-3561
97. Nikkhah G, Cunningham MG, Jodicke A, Knappe U, Bjorklund A (1994) Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633:133-143
98. Nikkhah G, Cunningham MG, McKay R, Bjorklund A (1995) Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. J Neurosci 5:3562-3570
99. Nikkhah G, Duan WM, Knappe U, Jodicke A, Bjorklund A (1993) Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 1:33-43
100. Nikkhah G, Olsson M, Eberhard J, Bentlage C, Cunningham MG, Bjorklund A (1994) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1:57-72
101. Nikkhah G, Winkler C, Roedter A, Samii M (2000) Microtransplantation of nigral dopamine neurons: a "step-bystep" recipe. In: Dunnett SB, Baker G (eds) NeuroMethods: Cell and Tissue Transplantation in the CNS. Humana, Totowa, pp 207-231
102. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L, Brosamle C, Kaupmann K, Vallon R, Schwab ME (2003) Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 13:5393-5406
103. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 3:403-414
104. Olsson M, Nikkhah G, Bentlage C, Bjorklund A (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 5:3863-3875
105. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 4393:643-647
106. Peschanski M, Defer G, N'Guyen JP, RicolfiF, Monfort JC, Remy P, Geny C, Samson Y, Hantraye P, Jeny R (1994) Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499
107. Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 12:1137-1140
108. Poewe W, Wenning GK (2000) Apomorphine: an underutilized therapy for Parkinson's disease. Mov Disord 5:789-794
109. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O (2007) Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells (in press)
110. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 20:1484-1491
111. Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL (2003) Limitations of current Parkinson's disease therapy. Ann Neurol 53:S3-S12
112. Rioux L, Gaudin DP, Bui LK, Gregoire L, DiPaolo T, Bedard PJ (1991) Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat. Neuroscience 1:123-131
113. Rioux L, Gaudin DP, Gagnon C, Di Paolo T, Bedard PJ (1991) Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants. Neuroscience 1:75-83
114. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N (2005) Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128:2240-2249
115. Rodter A, Winkler C, Samii M, Nikkhah G (2000) Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant 2:197-214
116. Roedter A, Winkler C, Samii M, Walter GF, Brandis A, Nikkhah G (2001) Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J Comp Neurol 2:217-229
117. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 11:1259-1268
118. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia VJ, Berger MS, Alvarez-Buylla A (2004) Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 6976:740-744
119. Schallert T, Hall S (1988) 'Disengage' sensorimotor deficit following apparent recovery from unilateral dopamine depletion. Behav Brain Res 1:15-24
120. Schallert T, De Ryck M, Whishaw IQ, Ramirez VD, Teitelbaum P (1979) Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism. Exp Neurol 1:33-43
121. Schallert T, Upchurch M, Lobaugh N, Farrar SB, Spirduso WW, Gilliam P, Vaughn D, Wilcox RE (1982) Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 3:455-462
122. Schmidt WJ (2000). Zur Verhaltensbiologie der Parkinson-Krankheit. Neuroforum 6:229-234
123. Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D (1999) The placebo response in Parkinson's disease. Parkinson Study Group. Clin Neuropharmacol 4:207-212
124. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, van der PH, Schwab ME (2003) Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2:201-211
125. Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O (2007) Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2:411-418
126. Stenevi U, Bjorklund A, Svendgaard NA (1976) Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res 1:1-20
127. Strecker RE, Sharp T, Brundin P, Zetterstrom T, Ungerstedt U, Bjorklund A (1987) Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 1:169-178
128. Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1:107-110
129. Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 3:485-493
130. van Praag H, Kempermann G, Gage FH (2000) Neural consequences of environmental enrichment. Nat Rev Neurosci 3:191-198
131. Vergara-Aragon P, Gonzalez CL, Whishaw IQ (2003) A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation. J Neurosci 2:579-586
132. Vuillet J, Moukhles H, Nieoullon A, Daszuta A (1994) Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells. Exp Brain Res 1:84-96
133. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O (1997) Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1:95-107
134. Whishaw IQ, Pellis SM (1990) The structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory component. Behav Brain Res 1:49-59
135. Whishaw IQ, Tomie JA (1988) Food wrenching and dodging: a neuroethological test of cortical and dopaminergic contributions to sensorimotor behavior in the rat. Behav Neurosci 1:110-123
136. Whishaw IQ, O'Connor WT, Dunnett SB (1986) The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain 109:805-843
137. Whishaw IQ, Woodward NC, Miklyaeva E, Pellis SM (1997) Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies. Behav Brain Res 89:167-177
138. Winkler C, Bentlage C, Cenci MA, Nikkhah G, Bjorklund A (2003) Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model. Neuroscience 4:1063-1077
139. Winkler C, Bentlage C, Nikkhah G, Samii M, Bjorklund A (1999) Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 2:165-186
140. Winkler C, Kirik D, Bjorklund A (2005) Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2:86-92
141. Winkler C, Kirik D, Bjorklund A, Dunnett SB (2000) Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog Brain Res 127:233-265
142. Yan WH, Cao MD, Liu JR, Xu Y, Han XF, Xing Y, Wang JZ (2005) Effects of EGF and bFGF on expression of microtubule-associated protein tau and MAP-2 mRNA in human umbilical cord mononuclear cells. Cell Biol Int 2:153-157
143. Zigmond MJ (1994) Chemical transmission in the brain: homeostatic regulation and its functional implications. Prog Brain Res 100:115-122